AACR logo

More articles from Oncogenes and Tumor Suppressors

Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma
Eric P. Rahrmann, Natalie K. Wolf, George M. Otto, Lynn Heltemes-Harris, Laura B. Ramsey, Jingmin Shu, Rebecca S. LaRue, Michael A. Linden, Susan K. Rathe, Timothy K. Starr, Michael A. Farrar, Branden S. Moriarity, David A. Largaespada

Molecular Cancer Research Feb 2019, 17 (2) 567-582; DOI: 10.1158/1541-7786.MCR-18-0582
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
Min Yao, Wei Fang, Curtis Smart, Qingting Hu, Shixia Huang, Nehemiah Alvarez, Patrick Fields, Nikki Cheng

Molecular Cancer Research Feb 2019, 17 (2) 604-617; DOI: 10.1158/1541-7786.MCR-18-0750
Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling
Wenhui Wang, Shan Li, Pengyu Liu, Kostandinos Sideras, Harmen J.G. van de Werken, Marieke van der Heide, Wanlu Cao, Marla Lavrijsen, Maikel P. Peppelenbosch, Marco Bruno, Qiuwei Pan, Ron Smits

Molecular Cancer Research Feb 2019, 17 (2) 521-531; DOI: 10.1158/1541-7786.MCR-18-0054
The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT
Molly R. Ryan, Christal D. Sohl, BeiBei Luo, Karen S. Anderson

Molecular Cancer Research Feb 2019, 17 (2) 532-543; DOI: 10.1158/1541-7786.MCR-18-0429
DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss
Chieh-Hsiang Chan, Chun-Ming Chen, Yan-Hwa Wu Lee, Li-Ru You

Molecular Cancer Research Feb 2019, 17 (2) 555-566; DOI: 10.1158/1541-7786.MCR-18-0551
c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL
Ho Yeon Lee, Junghwa Cha, Seon Kyu Kim, Jun Hyung Park, Ki Hoon Song, Pilnam Kim, Mi-Young Kim

Molecular Cancer Research Feb 2019, 17 (2) 544-554; DOI: 10.1158/1541-7786.MCR-18-0630
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance
Kenji Zennami, Su Mi Choi, Ross Liao, Ying Li, Wikum Dinalankara, Luigi Marchionni, Fatema H. Rafiqi, Akira Kurozumi, Koji Hatano, Shawn E. Lupold

Molecular Cancer Research Feb 2019, 17 (2) 618-627; DOI: 10.1158/1541-7786.MCR-18-0837
PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas
Kristen S. Hill, Evan R. Roberts, Xue Wang, Ellen Marin, Taeeun D. Park, Sorany Son, Yuan Ren, Bin Fang, Sean Yoder, Sungjune Kim, Lixin Wan, Amod A. Sarnaik, John M. Koomen, Jane L. Messina, Jamie K. Teer, Youngchul Kim, Jie Wu, Charles E. Chalfant, Minjung Kim

Molecular Cancer Research Feb 2019, 17 (2) 583-593; DOI: 10.1158/1541-7786.MCR-18-0777
Modulation of Mutant Kras^G12D-Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function
Xiaorong Zhou, Mahesh S. Padanad, Bret M. Evers, Bethany Smith, Nicole Novaresi, Shruthy Suresh, James A. Richardson, Emily Stein, Jingfei Zhu, Robert E. Hammer, Kathryn A. O'Donnell

Molecular Cancer Research Feb 2019, 17 (2) 594-603; DOI: 10.1158/1541-7786.MCR-18-0739
RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer
Mahsa Zarei, Shruti Lal, Ali Vaziri-Gohar, Kevin O'Hayer, Venugopal Gunda, Pankaj K. Singh, Jonathan R. Brody, Jordan M. Winter

Molecular Cancer Research Feb 2019, 17 (2) 508-520; DOI: 10.1158/1541-7786.MCR-18-0557

Main menu

User menu

Search

More articles from Oncogenes and Tumor Suppressors

Pages

Articles

Information for

About MCR